SCHEMBL28915005

SCHEMBL28915005

COc1cccc(OC)c1B1OC(C)(C)C(C)(C)O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.41
CA2 P00918 5/20 0.41
CA9 Q16790 4/20 0.41
CA7 P43166 3/20 0.41
CA12 O43570 2/20 0.41
CA14 Q9ULX7 2/20 0.41
CA4 P22748 1/20 0.41
LPL P06858 6/20 0.40
LIPG Q9Y5X9 6/20 0.40
ALDH1A1 P00352 2/20 0.38
TP53 P04637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26647695 0.89 CSF1R (0.38) CA1CA2CA9CA7CA12
SCHEMBL24558186 0.88 ALDH1A1 (0.46) CA1CA2CA9CA7CA12
SCHEMBL30526881 0.88 EGFR (0.37) CA1CA2CA9CA7CA12
SCHEMBL26058397 0.88 LPL (0.41) CA1CA2CA9CA7CA12
SCHEMBL31201012 0.86 SMN1; SMN2 (0.38) LPLLIPGALDH1A1LMNAMAPT
SCHEMBL31200670 0.85 L3MBTL1 (0.36) LPLLIPGALDH1A1KDM4EMAPT
SCHEMBL24558106 0.85 AR (0.37) CA1CA2CA9CA7CA12
SCHEMBL3446606 0.84 ERN1 (0.49) CA1CA2ALDH1A1KDM4ELMNA
SCHEMBL24558439 0.84 SIRT1 (0.39) CA1CA2CA9CA7CA12
SCHEMBL12389605 0.84 POLB (0.40) ALDH1A1KDM4EEGFRSMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250026766-A1 Thiazolopyridyl Amide Derivatives as DNA Polymerase Theta Inhibitors BEIGENE, LTD. (KY) 2025-01-23 US disclosed
EP-4463456-A1 THIAZOLOPYRIDYL AMIDE DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS BeiGene, Ltd. (KY) 2024-11-20 EP disclosed
WO-2023134708-A1 THIAZOLOPYRIDYL AMIDE DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS BEIGENE , LTD. (KY) 2023-07-20 WO disclosed
CN-115806557-A Compound for inhibiting programmed cell death and preparation method thereof 中国科学院上海有机化学研究所 2023-03-17 CN disclosed
CN-115490715-A Method for preparing aryl boronic acid pinacol ester compound by taking phenol as raw material 遵义医科大学 2022-12-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250026766-A1 Thiazolopyridyl Amide Derivatives as DNA Polymerase Theta Inhibitors POLQ, POLK, POLI CA1 3117/4885CA2 3068/4885CA9 3096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.